Table 4: Comparison of achievement on standards between phase 1 and phase 2   Criteria   Phase 1 (n=124)   Phase 2 (n=93)   Standard   Pearson Chi-square   Significance test result (p-value) 1. Uterus intact shown   59 (47.6%)   93 (100%)   95%   69.597   p<0.0001 2. Indicated for vasomotor symptom   16 (12.9%)   90 (96.7%)   95%   149.609   p<0.0001 3. Contraindication assessed   3 (2.4%)   93 (100%)   100%   205.133   p<0.0001 4. Not indicated for osteoporosis   32 (25.8%)   89 (95.7%)   95%   105.237   p<0.0001 5. Mammogram advised   43 (34.7%)   91 (97.8%)   95%   89.791   p<0.0001 6. Risk and benefit explained   9 (7.3%)   93 (100%)   95%   183.493   p<0.0001